SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-105643
Filing Date
2021-04-05
Accepted
2021-04-05 08:15:51
Documents
3
Period of Report
2021-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d151703d8k.htm 8-K 22193
2 EX-99.1 d151703dex991.htm EX-99.1 9918
3 GRAPHIC g151703g86u26.jpg GRAPHIC 8211
  Complete submission text file 0001193125-21-105643.txt   44822
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 21803780
SIC: 2834 Pharmaceutical Preparations